News and Events
UCSD Urology Ranked #22 in the Nation
UCSD Urology received its highest ranking ever this year from US News & World Report. "This is a great statement about our collective progress in building a distinguished and outstanding Urology Department," says Christopher J. Kane, MD, Chair. This is the fourth time the program was in the top 50 nationally in the last six years. In addition, UC San Diego Health System is ranked #1 in San Diego and among the best in the nation. Read more
Movember Spotlights Men's Health
Christopher J. Kane, MD, was interviewed by KPBS for the annual "Movember" event, which encourages men to grow a mustache for the month of November to raise awareness for prostate and testicular cancer and mental illness. Video and audio interviews
Moores Cancer Center Team Raises Funds with Pedal the Cause
Urology Department Chair Christopher J. Kane, MD and UC San Diego Health System CEO Paul Viviano were among the more than 400 cyclists who used pedal power to raise money for cancer research at the inaugural Pedal the Cause – San Diego held Oct. 25 and 26. Proceeds from the event benefit research at UC San Diego Moores Cancer Center, Sanford-Burnham Medical Research Institute and the Salk Institute for Biological Studies. Read more
MAN UP! Take Charge of Your Health - October 5, 2013
Drs. Mike Hsieh and Christopher Kane gave talks on men's sexual health after 40 and PSA screenings, respectively, at the free MAN UP! event held on the UC San Diego School of Medicine campus in La Jolla, Calif. The event, sponsored by the Mighty 1090AM radio station, also included talks on cardiovascular health, exercise, a male survival guide to stress, and a Q&A session. Read more
New Study on Kidney Sparing Surgery
Recent findings published by Ithaar Derweesh, MD, and colleagues show that patients most in need of kidney-sparing surgery are still more likely to undergo a total nephrectomy. Read more Abstract
Updated AUA Guidelines for Prostate Cancer Screening
The American Urological Association released updated guidelines for prostate cancer screening at its annual meeting in San Diego, recommending that men ages 55 through 69 with an average risk of developing prostate cancer receive prostate-specific antigen, or PSA, blood tests every two years. However, men with an increased risk of developing the disease, such as those who have had a close family member (father, uncles, brothers or cousins) diagnosed with prostate cancer and men of African-American ethnicity, are recommended to begin the screening process earlier, at age 45. Men in these two groups are also more likely to develop more aggressive forms of prostate cancer, according to J. Kellogg Parsons, MD. Read more
Ureteroscopy Use Rising, SWL Use Falling in California
The research of Hossein S. Mirheydar, MD, Roger L. Sur, MD, and colleagues was presented at the American Urological Association's annual meeting in San Diego and featured in Renal & Urology News. Ureteroscopy use has increased and shock wave lithotripsy use has decreased in California such that the two treatments for kidney stones are now being used at nearly equal rates. Read more and watch video
Demystifying Myths About Fertility - Free Seminar March 27
Join us at 6:00 p.m. on Wednesday March 27, 2013 for a free seminar by Mike Hsieh, MD, and Sanjay Agarwal, MD, at the Moores Cancer Center. More information and Registration Listen to Radio Ad
Watch interviews with Mike Haynes and Christopher Kane, MD, from the recent fundraiser at La Jolla Country Club.
- NFL Hall of Famer and prostate cancer survivor Mike Haynes participated in a fundraiser at the La Jolla Country Club on Friday, Feb. 22, 2013. Dr. Christopher Kane, Division Chief for Urology, gave an update on new detection methods for prostate cancer, and shared some of the exciting prostate cancer research taking place at UC San Diego.
UC San Diego Health System News
For more news on UC San Diego Health System, see Dept of Surgery News and Events.
US News and World Report ranked the Division of Urology No. 37, the highest ranking in the division's history and the third time that the division has been in the top 50 nationally in the last five years.
All faculty and residents are encouraged to attend the first Surgery Research Showcase and share your research with your colleagues.
The public is invited to learn about robotic surgeries at Moores Cancer Center and test-drive a da Vinci Surgical System as part of Cancer Survivor Week. Dr. Kader will present new robotic treatments for bladder cancer.
All San Diego Urologists, UCSD Alumni and Friends are invited to the Annual AUA Reception on May 21 at the Omni Hotel in Atlanta. See above link for details.
Dr. Kane asked for comment on Warren Buffett
Financier Warren Buffett was recently diagnosed with Stage 1 prostate cancer. MSNBC.com asks Division of Urology Chief Dr. Christopher Kane for his opinion on the prognosis. Read more
NIH Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements
An updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial was recently published in the Journal of the American Medical Association. According to J. Kellogg Parsons, MD, MHS, one of the authors, “SELECT has definitively shown a lack of benefit from vitamin E and selenium supplements in the prevention of prostate cancer, and has shown there are some real risks.” Read more
Kidney-Preserving Surgery and Reduced Risk of Osteoporosis
New research from UCSD and the University of Tennessee shows that, compared to radical nephrectomy, partial nephrectomy is associated with less risk of osteoporosis later in life. "When weighing the risks and benefits of partial versus radical nephrectomy, doctors and patients should take into account the impact on a patient's bone health," says Ithaar Derweesh, MD, Associate Professor at UCSD and senior author of the paper, published in Urology.
Dr. Kane Appointed C. Lowell & JoEllen Parsons Endowed Chair
In May 2011, internationally recognized cancer surgeon Dr. Christopher J. Kane became the inaugural holder of the C. Lowell and JoEllen Parsons Endowed Chair in Urology. The $2.5 million endowed faculty chair will enable Dr. Kane to recruit world-class talent and support novel research, cancer treatment and prevention programs at UC San Diego Health System. Read more
Diet and Prostate Cancer Trial
UC San Diego is launching the nation's first non-supplement study on prostate cancer and diet. Participants in the Men's Eating and Living (MEAL) study will eat at least seven servings of colorful, strong-flavored produce per day, with an emphasis on cruciferous vegetables and tomato products, as well as whole grains, beans or other legumes, and fruit. "Ours is the first study to focus on changing the entire lifestyle rather than just giving the participants a supplement pill," says Dr. J. Kellogg Parsons,urologic oncologist at the UCSD Moores Cancer Center. Read more about the MEAL study or watch the 10News video coverage.
San Diego's Top Doctors 2011
Michael Albo, MD, J. Kellogg Parsons, MD, and Christopher Kane, MD were named among San Diego's Top Doctors by the San Diego County Medical Society, in partnership with San Diego Magazine. This is the eighth consecutive year Albo has received this recognition, the second consecutive year for Parsons, and the third consecutive year for Kane.
Health Care Champion
The San Diego Business Journal recognized Christopher J. Kane, MD, as Health Care Champion-Physician for 2010.
Reviewers of the Year
The June 2010 issue of the Journal of Urology recognizes Dr. C. Lowell Parsons as Best Reviewer of the Year in the field of urodynamics/incontinence/female urology, and Dr. J. Kellogg Parsons as Outstanding Reviewer of the Year in the field of benign prostatic hyperplasia. (Article access restricted to UC campuses.)
Novel Treatment Shrinks and Removes Large Tumors, Saves Kidneys
A team of UCSD researchers led by Dr. Ithaar Derweesh has successfully used sunitinib to shrink large kidney tumors in patients at high risk for kidney failure. They then surgically removed the tumors and reconstructed the kidneys. Patients did not require dialysis after surgery. The study was published in the April 2010 issue of BJU International. Read more.
Risk of Stones After Radical vs Partial Nephrectomy
A new study by Ithaar Derweesh, MD, and colleagues found that patients undergoing partial nephrectomy have a significantly decreased incidence of postoperative nephrolithiasis compared to those undergoing radical nephrectomy. This is the largest single-institution study ever conducted to evaluate the association of radical versus partial nephrectomy with subsequent stone formation. Read more in BJU International.
Prostate Cancer Treated Differently at County vs Private Hospitals
A study headed by UC San Diego's J. Kellogg Parsons, MD found that treatment decisions among economically disadvantaged men with prostate cancer are related to the type of facility where they are treated.
Parsons and colleagues at UCLA compared the types of treatments received by 559 men enrolled in a state-funded program for low-income patients, Improving Access, Counseling and Treatment for Californians with Prostate Cancer (IMPACT). Those who were treated at private hospitals were found to be two and half times more likely than those at county hospitals to receive radiation therapy and four and a half times more likely to initially receive hormone therapy instead of surgery.
While the reasons for these differences in treatment decisions are not known, the type of doctor that patients see may play a role. At county hospitals, patients were initially under the care of urologists, while the initial providers at private facilities were urologists, radiation oncologists, and medical oncologists.
These differences have "implications for health policy, quality of care, and equality of care—particularly because public hospitals are funded by city and state governments to provide health care for underserved, poor populations,” said Parsons.
The study was published in the March 2010 issue of the journal Cancer.
Single-Incision Tumor Removal and Kidney Reconstruction
A team of surgeons led by Dr. Ithaar Derweesh performed a complex, single-incision surgery to remove a kidney tumor while preserving and then reconstructing the remaining healthy kidney. The UCSD team is the second in the world to perform this procedure. Read more.
Medical News Base
Medical News Today
See also: KPBS
New Drug Provides Hope for Sufferers of Interstitial Cystitis/Painful Bladder Syndrome
A new patent has been issued for an experimental drug therapy developed by Dr. C. Lowell Parsons. The drug therapy, which has yielded positive results in a recent Phase 2 study, is a combination of an anesthetic and heparin delivered directly into the bladder via a catheter. The anesthetic provides rapid pain relief while heparin restores the protective mucus layer of the bladder. Read more.
New York Times
Medical News Today
America’s Best Children's Hospitals
The 2010 childrens hospital rankings from U.S. News & World Report rank Rady Children's Hospital-San Diego number 12 in the country for pediatric urologic care.